Home » The Future of Regenerative Medicine: Exploring the Potential of Additive Manufacturing

The Future of Regenerative Medicine: Exploring the Potential of Additive Manufacturing

by admin
The Future of Regenerative Medicine: Exploring the Potential of Additive Manufacturing

Tecnalia Research Team Explores Potential of 3D Bioprinting in Regenerative Medicine

Is additive manufacturing the future of regenerative medicine? This is the question that a research team at the Tecnalia technology center is asking as they study the potential of 3D bioprinting. This cutting-edge technology has the potential to change the paradigm of regenerative medicine and advanced therapies. The team is currently conducting research in three lines of biomaterials for health: personalized implants, injectable and printable vehicles, and therapies and three-dimensional models in vitro for advanced crops. Additionally, they are exploring the possibilities of 4D printing, a “smart” manufacturing method that offers additional properties to the models created.

The development of additive manufacturing in the medical field is already making significant progress, with many hospitals and health centers implementing technology to offer personalized care to their patients. Whether for the creation of 3D organs and tissues, or for the manufacture of implants or adapted medical devices, 3D printing offers extensive benefits in this sector. The Tecnalia team hopes to further advance the development of materials for 3D bioprinting, tailored to various additive technologies, covering their physicochemical, mechanical, and biological processing and validation.

Tecnalia has access to the main additive technologies used in the field of medicine, including fused deposition modeling (FDM), pellet 3D printing, electrospinning, stereolithography (SLA), and 3D bioprinting. For 3D bioprinting, experts are creating bioinks that meet biological requirements and ensure optimal printing. This allows various biomaterials to be incorporated into the formulation of the same bioink, enabling the transport of different cell types and therapies.

In addition to traditional 3D bioprinting, two new concepts have emerged: 4D bioprinting introduces an additional temporal dimension, allowing the manufacturing of a structure capable of transforming in response to various stimuli, and bioprinting “alive” enables 3D printing models directly on the patient.

See also  Insomnia? Smartwatch and smartband to promote sleep

The research into additive technology in the fields of regenerative medicine and advanced therapies is a significant milestone for the technology center. The Tecnalia team is committed to integrating these technologies to create solutions that comprehensively mimic all aspects of native tissues, both in their structure and biochemical composition. The next step will be to evaluate the results obtained from this research, which could offer treatment more adapted to the needs of patients.

What do you think of the research carried out by Tecnalia on the use of 3D bioprinting in medicine? Let us know your thoughts on our social networks: Facebook, Twitter, and YouTube. Stay updated on all the latest information about 3D printing in our weekly newsletter.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy